Nano-X Imaging (NNOX) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

NNOX Stock Forecast


Nano-X Imaging stock forecast is as follows: an average price target of $18.00 (represents a 166.27% upside from NNOX’s last price of $6.76) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

NNOX Price Target


The average price target for Nano-X Imaging (NNOX) is $18.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $18.00 to $18.00. This represents a potential 166.27% upside from NNOX's last price of $6.76.

NNOX Analyst Ratings


Buy

According to 2 Wall Street analysts, Nano-X Imaging's rating consensus is 'Buy'. The analyst rating breakdown for NNOX stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Nano-X Imaging Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 02, 2024Ross OsbornCantor Fitzgerald$18.00$10.3374.25%166.27%

The latest Nano-X Imaging stock forecast, released on Apr 02, 2024 by Ross Osborn from Cantor Fitzgerald, set a price target of $18.00, which represents a 74.25% increase from the stock price at the time of the forecast ($10.33), and a 166.27% increase from NNOX last price ($6.76).

Nano-X Imaging Price Target by Period


1M3M12M
# Anlaysts--1
Avg Price Target--$18.00
Last Closing Price$6.76$6.76$6.76
Upside/Downside-100.00%-100.00%166.27%

In the current month, the average price target of Nano-X Imaging stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Nano-X Imaging's last price of $6.76. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Dec 05, 2024Cantor FitzgeraldOverweightOverweightHold
Apr 02, 2024Cantor FitzgeraldOverweightOverweightHold
Jan 19, 2024Cantor FitzgeraldOverweightOverweightHold
Sep 08, 2023Alliance Global PartnersBuyInitialise

Nano-X Imaging's last stock rating was published by Cantor Fitzgerald on Dec 05, 2024. The company gave NNOX a "Overweight" rating, the same as its previous rate.

Nano-X Imaging Financial Forecast


Nano-X Imaging Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
Revenue---------------$2.45M$2.13M$2.44M$2.20M$1.81M$1.30M
Avg Forecast$41.20M$27.40M$20.20M$14.20M$14.35M$10.10M$7.90M$5.50M$3.80M$3.91M$3.93M$4.42M$2.82M$2.90M$3.15M$2.90M$2.65M$2.81M$2.35M$2.38M$750.00K
High Forecast$44.30M$29.46M$21.72M$15.27M$15.43M$10.86M$8.49M$5.80M$4.20M$4.20M$3.93M$4.75M$3.57M$3.12M$3.39M$3.11M$2.84M$2.81M$2.35M$2.38M$750.00K
Low Forecast$36.77M$24.45M$18.03M$12.67M$12.81M$9.01M$7.05M$5.20M$3.10M$3.49M$3.93M$3.94M$2.10M$2.59M$2.82M$2.58M$2.36M$2.81M$2.35M$2.38M$750.00K
# Analysts111111123222311111111
Surprise %---------------0.85%0.81%0.87%0.94%0.76%1.74%

Nano-X Imaging's average Quarter revenue forecast for Jun 23 based on 1 analysts is $3.15M, with a low forecast of $2.82M, and a high forecast of $3.39M. NNOX's average Quarter revenue forecast represents a 28.93% increase compared to the company's last Quarter revenue of $2.45M (Mar 23).

Nano-X Imaging EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts111111123222311111111
EBITDA---------------$-18.31M$12.10M$-15.05M$-15.92M$-19.08M$-22.04M
Avg Forecast$-8.24M$-5.48M$-4.04M$-2.84M$-2.87M$-2.02M$-1.58M$-1.10M$-760.00K$-781.62K$-786.13K$-883.00K$-564.67K$-580.00K$-631.00K$-579.00K$-529.00K$-563.00K$-469.00K$-477.00K$-150.00K
High Forecast$-7.35M$-4.89M$-3.61M$-2.53M$-2.56M$-1.80M$-1.41M$-1.04M$-620.00K$-697.57K$-786.09K$-788.05K$-420.50K$-517.63K$-563.15K$-516.74K$-472.12K$-563.00K$-469.00K$-477.00K$-150.00K
Low Forecast$-8.86M$-5.89M$-4.34M$-3.05M$-3.09M$-2.17M$-1.70M$-1.16M$-840.00K$-840.45K$-786.16K$-949.46K$-714.84K$-623.65K$-678.49K$-622.58K$-568.82K$-563.00K$-469.00K$-477.00K$-150.00K
Surprise %---------------31.63%-22.88%26.73%33.94%40.01%146.90%

1 analysts predict NNOX's average Quarter EBITDA for Mar 23 to be $-579.00K, with a high of $-516.74K and a low of $-622.58K. This is -104.78% lower than Nano-X Imaging's previous annual EBITDA (Dec 22) of $12.10M.

Nano-X Imaging Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts111111123222311111111
Net Income---------------$-11.76M$-44.84M$-19.13M$-19.61M$-21.67M$-20.18M
Avg Forecast$3.52M$-1.17M$-4.10M$-6.45M$-7.33M$-8.50M$-9.67M$-10.55M$-13.29M$-12.72M$-12.66M$-15.24M$-17.78M$-17.59M$-15.54M$-19.93M$-25.21M$-24.36M$-14.69M$-14.79M$-19.14M
High Forecast$3.86M$-1.01M$-3.53M$-5.55M$-6.30M$-7.31M$-8.32M$-9.08M$-11.43M$-10.94M$-10.89M$-13.11M$-14.23M$-15.13M$-13.36M$-17.15M$-21.68M$-24.36M$-14.69M$-14.79M$-19.14M
Low Forecast$3.03M$-1.29M$-4.51M$-7.08M$-8.04M$-9.33M$-10.62M$-11.58M$-14.59M$-13.97M$-13.90M$-16.73M$-22.52M$-19.31M$-17.06M$-21.88M$-27.68M$-24.36M$-14.69M$-14.79M$-19.14M
Surprise %---------------0.59%1.78%0.79%1.33%1.46%1.05%

Nano-X Imaging's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. NNOX's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Nano-X Imaging SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts111111123222311111111
SG&A---------------$8.96M$9.68M$11.33M$12.23M$12.39M$12.86M
Avg Forecast$347.70M$231.24M$170.48M$119.84M$121.10M$85.24M$66.67M$46.42M$32.07M$32.98M$33.17M$37.26M$23.83M$24.47M$26.63M$24.43M$22.32M$23.74M$19.77M$20.11M$6.32M
High Forecast$373.87M$248.64M$183.31M$128.86M$130.22M$91.65M$71.69M$48.95M$35.45M$35.46M$33.17M$40.06M$30.16M$26.32M$28.63M$26.27M$24.00M$23.74M$19.77M$20.11M$6.32M
Low Forecast$310.31M$206.37M$152.14M$106.95M$108.08M$76.07M$59.50M$43.88M$26.16M$29.44M$33.17M$33.25M$17.74M$21.84M$23.76M$21.80M$19.92M$23.74M$19.77M$20.11M$6.32M
Surprise %---------------0.37%0.43%0.48%0.62%0.62%2.03%

Nano-X Imaging's average Quarter SG&A projection for Jun 23 is $26.63M, based on 1 Wall Street analysts, with a range of $23.76M to $28.63M. The forecast indicates a 197.13% rise compared to NNOX last annual SG&A of $8.96M (Mar 23).

Nano-X Imaging EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts111111123222311111111
EPS---------------$-0.21$-0.86$-0.37$-0.38$-0.42$-0.42
Avg Forecast$0.06$-0.02$-0.07$-0.11$-0.13$-0.14$-0.17$-0.18$-0.23$-0.22$-0.22$-0.26$-0.30$-0.30$-0.27$-0.34$-0.43$-0.42$-0.25$-0.26$-0.33
High Forecast$0.07$-0.02$-0.06$-0.09$-0.11$-0.12$-0.14$-0.15$-0.19$-0.19$-0.19$-0.22$-0.24$-0.26$-0.23$-0.29$-0.37$-0.42$-0.25$-0.26$-0.33
Low Forecast$0.05$-0.02$-0.08$-0.12$-0.14$-0.16$-0.18$-0.20$-0.25$-0.24$-0.24$-0.29$-0.38$-0.33$-0.29$-0.37$-0.47$-0.42$-0.25$-0.26$-0.33
Surprise %---------------0.62%2.00%0.88%1.50%1.65%1.27%

According to undefined Wall Street analysts, Nano-X Imaging's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to NNOX previous annual EPS of $NaN (undefined).

Nano-X Imaging Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
NNOXNano-X Imaging$7.31$18.00146.24%Buy
HYPRHyperfine$0.94$1.6070.21%Buy
PACBPacific Biosciences of California$1.97$3.0052.28%Buy
DXCMDexCom$77.80$104.5034.32%Buy
MDTMedtronic$81.37$95.4017.24%Hold
ALGNAlign$228.81$264.1715.45%Buy
SYKStryker$370.81$408.3310.12%Buy
ABTAbbott Laboratories$113.29$120.096.00%Buy
EWEdwards Lifesciences$74.12$76.332.98%Buy
AXNXAxonics$70.98$71.000.03%Buy
IARTIntegra LifeSciences$23.03$23.00-0.13%Sell
NVCRNovoCure$32.10$30.00-6.54%Hold

NNOX Forecast FAQ


Is Nano-X Imaging a good buy?

Yes, according to 2 Wall Street analysts, Nano-X Imaging (NNOX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of NNOX's total ratings.

What is NNOX's price target?

Nano-X Imaging (NNOX) average price target is $18 with a range of $18 to $18, implying a 166.27% from its last price of $6.76. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Nano-X Imaging stock go up soon?

According to Wall Street analysts' prediction for NNOX stock, the company can go up by 166.27% (from the last price of $6.76 to the average price target of $18), up by 166.27% based on the highest stock price target, and up by 166.27% based on the lowest stock price target.

Can Nano-X Imaging stock reach $10?

NNOX's average twelve months analyst stock price target of $18 supports the claim that Nano-X Imaging can reach $10 in the near future.

What are Nano-X Imaging's analysts' financial forecasts?

Nano-X Imaging's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $37.85M (high $40.58M, low $34.07M), average EBITDA is $-7.57M (high $-6.814M, low $-8.117M), average net income is $-36.054M (high $-31.014M, low $-39.582M), average SG&A $319.43M (high $342.51M, low $287.54M), and average EPS is $-0.615 (high $-0.529, low $-0.675). NNOX's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $103M (high $110.75M, low $91.92M), average EBITDA is $-20.6M (high $-18.385M, low $-22.151M), average net income is $-8.207M (high $-6.224M, low $-9.846M), average SG&A $869.25M (high $934.68M, low $775.79M), and average EPS is $-0.14 (high $-0.106, low $-0.168).

Did the NNOX's actual financial results beat the analysts' financial forecasts?

Based on Nano-X Imaging's last annual report (Dec 2022), the company's revenue was $8.58M, which missed the average analysts forecast of $10.19M by -15.82%. Apple's EBITDA was $-37.194M, beating the average prediction of $-2.038M by 1725.03%. The company's net income was $-105M, beating the average estimation of $-79.056M by 33.12%. Apple's SG&A was $45.63M, missing the average forecast of $85.94M by -46.91%. Lastly, the company's EPS was $-2.01, beating the average prediction of $-1.358 by 47.98%. In terms of the last quarterly report (Mar 2023), Nano-X Imaging's revenue was $2.45M, missing the average analysts' forecast of $2.9M by -15.47%. The company's EBITDA was $-18.312M, beating the average prediction of $-579K by 3062.70%. Nano-X Imaging's net income was $-11.761M, missing the average estimation of $-19.932M by -40.99%. The company's SG&A was $8.96M, missing the average forecast of $24.43M by -63.32%. Lastly, the company's EPS was $-0.21, missing the average prediction of $-0.34 by -38.24%